Boehringer Ingelheim

Senior Brand Manager - Cardio, Renal, Metabolic - New Product Launch (Sydney, AU, Australia, NSW)

Sydney, Australia Type not listed
Manager

Boehringer Ingelheim is the source of truth for this posting and owns the application process. We surface normalized context and market comparison you won't find on the original listing.

About this opportunity

The Opportunity

Join Boehringer Ingelheim at a pivotal moment to shape the future of obesity and metabolic health. This is a rare launch role, where you will play a key role in shaping the launch and commercialisation of Survodutide, a next-generation therapy with the potential to redefine patient outcomes.

Working in a dynamic, cross-functional environment, you will lead end-to-end brand strategy for a pre-launch and launch asset, translating insight into action and building a focused market entry strategy in a competitive and rapidly evolving market.

Given the importance of this launch, we are seeking a candidate who can thrive in ambiguity, shape the market, and build a brand from the ground up.

This role offers strong career progression, with the opportunity to step into a future leadership position and build and lead a high-performing brand team as the franchise grows.

Key Responsibilities

Launch & Brand Strategy

Lead development and execution of the end-to-end launch readiness (LR) for Survodutide in Australia

Build and implement Integrated Customer Plans (ICP) aligned to pre-launch and launch milestones

Develop segmentation, targeting and positioning strategies grounded in deep customer insight

Define value proposition and messaging across obesity and metabolic health stakeholders

Commercial Planning & Performance

Develop robust launch scenarios, and business cases (LR/ICP aligned)

Monitor brand performance and optimise investment based on ROI and market dynamics

Lead competitive intelligence to inform strategic decision-making in a fast-moving market

Cross-functional Leadership

Act as the central connector across Medical, Market Access, Sales, Regulatory, and regional teams

Lead agency partners to deliver best-in-class omnichannel campaigns

Support field force readiness, including value communication and customer engagement frameworks

Execution Excellence

Deliver high impact omnichannel campaigns, congress strategy, and customer engagement plans

Ensure all activities meet compliance, governance, and quality standards

Maintain strong operational discipline across budget, timelines, and delivery milestones

Your Profile

Experience & Capability

5+ years in pharmaceutical brand management, ideally with launch experience

Experience in obesity, diabetes, or cardio-metabolic disease strongly preferred

Proven success in pre-launch or launch environments, including market shaping

Strong track record in strategic planning (ICP and launch readiness), forecasting, and performance delivery

Skills & Mindset

Highly analytical with the ability to translate data into clear commercial action

Strong stakeholder engagement skills, with the ability to influence cross-functional teams

Experience leading complex, multi-channel marketing programs

Entrepreneurial mindset with a passion for innovation, growth, and patient impact

What’s next? - How to apply

If you would like to be part of this highly driven and successful team, please submit your CV addressing the key criteria above.

You must have the right to live and work in this location to be considered for this opportunity.

It is our policy not to accept speculative resumes from recruitment agencies.

Position Area

Human Pharma

Position Location

NSW

Organization

Boehringer Ingelheim

Schedule

Full-Time

#LI-BI

]]>

Job details

Seniority
Manager
Function
Not listed
Therapeutic area
Not listed
Location
Sydney, Australia
Employment type
Not listed

How this role compares

Computed from every other active role in our database, not just this employer's listings.

We don't have enough classified peer data for this role yet, so there's no comparison to show. This happens when a posting's title/category doesn't match any taxonomy rule -- it's excluded rather than compared against the wrong peer group.